Phase II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy

J. M. Denefrio, Charles Vogel

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

In the present dose and schedule, the authors found hexamethylmelamine to be ineffective in the management of metastatic breast cancer already refractory to standard chemotherapy and hormonal therapeutic approaches in 19 cases.

Original languageEnglish
Pages (from-to)173-175
Number of pages3
JournalCancer Treatment Reports
Volume62
Issue number1
StatePublished - Jan 1 1978

Fingerprint

Altretamine
Appointments and Schedules
Breast Neoplasms
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Phase II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy. / Denefrio, J. M.; Vogel, Charles.

In: Cancer Treatment Reports, Vol. 62, No. 1, 01.01.1978, p. 173-175.

Research output: Contribution to journalArticle

@article{2ce50eac7324434e91da588f132e1626,
title = "Phase II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy",
abstract = "In the present dose and schedule, the authors found hexamethylmelamine to be ineffective in the management of metastatic breast cancer already refractory to standard chemotherapy and hormonal therapeutic approaches in 19 cases.",
author = "Denefrio, {J. M.} and Charles Vogel",
year = "1978",
month = "1",
day = "1",
language = "English",
volume = "62",
pages = "173--175",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Phase II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy

AU - Denefrio, J. M.

AU - Vogel, Charles

PY - 1978/1/1

Y1 - 1978/1/1

N2 - In the present dose and schedule, the authors found hexamethylmelamine to be ineffective in the management of metastatic breast cancer already refractory to standard chemotherapy and hormonal therapeutic approaches in 19 cases.

AB - In the present dose and schedule, the authors found hexamethylmelamine to be ineffective in the management of metastatic breast cancer already refractory to standard chemotherapy and hormonal therapeutic approaches in 19 cases.

UR - http://www.scopus.com/inward/record.url?scp=0017904268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017904268&partnerID=8YFLogxK

M3 - Article

C2 - 414835

AN - SCOPUS:0017904268

VL - 62

SP - 173

EP - 175

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 1

ER -